217 related articles for article (PubMed ID: 9826471)
1. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
Varia MA; Calkins-Adams DP; Rinker LH; Kennedy AS; Novotny DB; Fowler WC; Raleigh JA
Gynecol Oncol; 1998 Nov; 71(2):270-7. PubMed ID: 9826471
[TBL] [Abstract][Full Text] [Related]
2. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
Raleigh JA; Chou SC; Calkins-Adams DP; Ballenger CA; Novotny DB; Varia MA
Clin Cancer Res; 2000 Mar; 6(3):855-62. PubMed ID: 10741707
[TBL] [Abstract][Full Text] [Related]
3. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
Kennedy AS; Raleigh JA; Perez GM; Calkins DP; Thrall DE; Novotny DB; Varia MA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):897-905. PubMed ID: 9128967
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.
Raleigh JA; Calkins-Adams DP; Rinker LH; Ballenger CA; Weissler MC; Fowler WC; Novotny DB; Varia MA
Cancer Res; 1998 Sep; 58(17):3765-8. PubMed ID: 9731480
[TBL] [Abstract][Full Text] [Related]
5. The fate of hypoxic (pimonidazole-labelled) cells in human cervix tumours undergoing chemo-radiotherapy.
Durand RE; Aquino-Parsons C
Radiother Oncol; 2006 Aug; 80(2):138-42. PubMed ID: 16916562
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
[TBL] [Abstract][Full Text] [Related]
7. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
Vordermark D; Brown JM
Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
[TBL] [Abstract][Full Text] [Related]
8. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
Olive PL; Durand RE; Raleigh JA; Luo C; Aquino-Parsons C
Br J Cancer; 2000 Dec; 83(11):1525-31. PubMed ID: 11076663
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.
Carnell DM; Smith RE; Daley FM; Saunders MI; Bentzen SM; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):91-9. PubMed ID: 16563659
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.
Hoogsteen IJ; Peeters WJ; Marres HA; Rijken PF; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2005 Aug; 76(2):213-8. PubMed ID: 16112214
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
Goethals L; Debucquoy A; Perneel C; Geboes K; Ectors N; De Schutter H; Penninckx F; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):246-54. PubMed ID: 16618579
[TBL] [Abstract][Full Text] [Related]
13. The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma.
Hoskin PJ; Sibtain A; Daley FM; Saunders MI; Wilson GD
Radiother Oncol; 2004 Aug; 72(2):159-68. PubMed ID: 15297134
[TBL] [Abstract][Full Text] [Related]
14. Identification of nonproliferating but viable hypoxic tumor cells in vivo.
Durand RE; Raleigh JA
Cancer Res; 1998 Aug; 58(16):3547-50. PubMed ID: 9721858
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia and differentiation in squamous cell carcinomas of the uterine cervix: pimonidazole and involucrin.
Azuma Y; Chou SC; Lininger RA; Murphy BJ; Varia MA; Raleigh JA
Clin Cancer Res; 2003 Oct; 9(13):4944-52. PubMed ID: 14581369
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.
Nordsmark M; Loncaster J; Aquino-Parsons C; Chou SC; Gebski V; West C; Lindegaard JC; Havsteen H; Davidson SE; Hunter R; Raleigh JA; Overgaard J
Radiother Oncol; 2006 Aug; 80(2):123-31. PubMed ID: 16890316
[TBL] [Abstract][Full Text] [Related]
17. A clinical study of hypoxia using endogenous hypoxic markers and polarographic oxygen electrodes.
Sakata K; Someya M; Nagakura H; Nakata K; Oouchi A; Hareyama M; Satoh M
Strahlenther Onkol; 2006 Sep; 182(9):511-7. PubMed ID: 16944372
[TBL] [Abstract][Full Text] [Related]
18. pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
Ellingsen C; Ovrebø KM; Galappathi K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1317-23. PubMed ID: 22270159
[TBL] [Abstract][Full Text] [Related]
19. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.
Yaromina A; Zips D; Thames HD; Eicheler W; Krause M; Rosner A; Haase M; Petersen C; Raleigh JA; Quennet V; Walenta S; Mueller-Klieser W; Baumann M
Radiother Oncol; 2006 Nov; 81(2):122-9. PubMed ID: 16956683
[TBL] [Abstract][Full Text] [Related]
20. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry.
Gulliksrud K; Vestvik IK; Galappathi K; Mathiesen B; Rofstad EK
Radiat Res; 2008 Nov; 170(5):638-50. PubMed ID: 18959463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
